John Demaree
2019
In 2019, John Demaree earned a total compensation of $1.3M as Chief Commercial Officer at G1 Therapeutics, a 82% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $60,000 |
|---|---|
| Option Awards | $832,040 |
| Salary | $375,000 |
| Other | $65,147 |
| Total | $1,332,188 |
Demaree received $832K in option awards, accounting for 62% of the total pay in 2019.
Demaree also received $60K in non-equity incentive plan, $375K in salary and $65.1K in other compensation.
Rankings
In 2019, John Demaree's compensation ranked 7,920th out of 13,971 executives tracked by ExecPay. In other words, Demaree earned more than 43.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,920 out of 13,971 | 43rd |
Division Manufacturing | 3,116 out of 5,701 | 45th |
Major group Chemicals And Allied Products | 1,179 out of 2,200 | 46th |
Industry group Drugs | 1,007 out of 1,886 | 47th |
Industry Pharmaceutical Preparations | 748 out of 1,398 | 47th |
Pay ratio
| John Demaree's Pay | $1,332,188 |
|---|---|
| Median Employee's Pay | $213,060 |
| Pay Ratio | 6to 1 |
In 2019, the annual total compensation of John Demaree was $1,332,188.
The annual total compensation of the median employee at G1 Therapeutics was $213,060.
The ratio of John Demaree's pay to the pay of median employee was therefore 6 to one.
Source: SEC filing on April 24, 2020.
Demaree's colleagues
We found five more compensation records of executives who worked with John Demaree at G1 Therapeutics in 2019.